Product

Levosulpiride

Aliases

dopamine D2 receptor blocker

1 clinical trial

2 indications

Indication

Diabetic Macular Edema

Indication

Diabetic Retinopathy

Clinical trial

Clinical Trial to Evaluate the Safety and Efficacy of Levosulpiride to Improve Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema.

Status: Recruiting, Estimated PCD: 2025-06-01